Therefore, hypoalbuminemia in patients with liver cirrhosis may result in alteration in the proposed protein-facilitated metabolism of drugs and endogenous substances (e.g. cholesterol & sex steroids) which are metabolized by CYP3A4 (Baba et al. 2002). The gene discussed is CYP3A4; the disease is Hypoalbuminemia.